In Vitro Activities of 21 Antimicrobial Agents Alone and in Combination with Aminoglycosides or Fluoroquinolones against Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates Causing Bacteremia

被引：18
|
作者：
Cha, Min Kyeong [1 ]
Kang, Cheol-In [2 ]
Kim, So Hyun [1 ,2 ]
Cho, Sun Young [2 ]
Ha, Young Eun [2 ]
Wi, Yu Mi [3 ]
Chung, Doo Ryeon [1 ,2 ]
Peck, Kyong Ran [2 ]
Song, Jae-Hoon [1 ,2 ]
机构：
[1] APFID, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Infect Dis, Chang Won, South Korea
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2015年 / 59卷 / 09期
基金：
新加坡国家研究基金会;
关键词：
ANTIBIOTIC-THERAPY; MOLECULAR EPIDEMIOLOGY; SEPTIC SHOCK; RISK-FACTORS; INFECTIONS; SEPSIS; MONOTHERAPY; IMPACT;
D O I：
10.1128/AAC.01121-15
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
We evaluated the in vitro activity of various antimicrobials alone and in combination against 291 extended-spectrum-beta-lactamase-producing Escherichia coli (ESBL-EC) isolates causing bacteremia in South Korean hospitals. Ceftazidime, cefepime, and piperacillin-tazobactam in combination with amikacin showed greater activity than found in combination with ciprofloxacin. In settings with a high prevalence of ESBL-producing pathogens, combination aminoglycoside antimicrobial therapy, especially with amikacin, may be considered for empirical therapy against suspected Gram-negative sepsis as a carbapenem-saving strategy.
引用
收藏
页码：5834 / 5837
页数：4
相关论文
共 50 条
  • [31] Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy
    Kang, Cheol-In
    Chung, Doo Ryeon
    Ko, Kwan Soo
    Peck, Kyong Ran
    Song, Jae-Hoon
    ANNALS OF HEMATOLOGY, 2012, 91 (01) : 115 - 121
  • [32] Clinical characteristics and outcome of critically ill patients with bacteremia caused by extended-spectrum β-lactamase-producing and non-producing Escherichia coli
    Haruki, Yuto
    Hagiya, Hideharu
    Haruki, Mai
    Sugiyama, Tetsuhiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2018, 24 (11) : 944 - 947
  • [33] Extended-spectrum β-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia
    Lee, Chih-I
    Lee, Nan-Yao
    Yan, Jing-Jou
    Lee, Hsin-Chun
    Ko, Nai-Ying
    Chang, Chia-Ming
    Wu, Chi-Jung
    Chen, Po-Ling
    Wang, Li-Rong
    Ko, Wen-Chien
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2009, 42 (04) : 303 - 309
  • [34] Prevalence and risk factors for extended-spectrum β-lactamase-producing Escherichia coli causing community-onset urinary tract infections in Colombia
    Blanco, Victor M.
    Maya, Juan J.
    Correa, Adriana
    Perenguez, Marcela
    Munoz, Juan S.
    Motoa, Gabriel
    Pallares, Christian J.
    Rosso, Fernando
    Matta, Lorena
    Celis, Yamile
    Garzon, Martha
    Villegas, Maria V.
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2016, 34 (09): : 559 - 565
  • [35] β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
    Rodriguez-Bano, Jesus
    Navarro, Maria Dolores
    Retamar, Pilar
    Picon, Encarnacion
    Pascual, Alvaro
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (02) : 167 - 174
  • [36] Genomic Determinants and Antimicrobial Resistance Pattern of Clinical Isolates of Extended Spectrum Beta Lactamase (ESBL) Producing Escherichia coli
    Shah, Hamid Ahmad
    Syed, Arshi
    Bhat, Mohd Altaf
    Kakru, Dalip K.
    Farooq, Shaheen
    Qureshi, Sabia
    Shafi, Azhar
    Nabi, Burhan
    Taku, Anil
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2023, 17 (03) : 1679 - 1690
  • [37] In vitro activity of tigecycline against extended-spectrum β-lactamase-producing Enterobacteriaceae and MRSA clinical isolates from Mexico: a multicentric study
    Silva-Sanchez, Jesus
    Reyna-Flores, Fernando
    Elena Velazquez-Meza, Ma.
    Rojas-Moreno, Teresa
    Benitez-Diaz, Arturo
    Sanchez-Perez, Alejandro
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2011, 70 (02) : 270 - 273
  • [38] Severe Sepsis Facilitates Intestinal Colonization by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae and Transfer of the SHV-18 Resistance Gene to Escherichia coli during Antimicrobial Treatment
    Guan, Jun
    Liu, Shaoze
    Lin, Zhaofen
    Li, Wenfang
    Liu, Xuefeng
    Chen, Dechang
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) : 1039 - 1046
  • [39] Escherichia coli Sequence Type 131 H30 Is the Main Driver of Emerging Extended-Spectrum-β-Lactamase-Producing E. coli at a Tertiary Care Center
    Johnson, James R.
    Johnston, Brian
    Thuras, Paul
    Launer, Bryn
    Sokurenko, Evgeni V.
    Miller, Loren G.
    MSPHERE, 2016, 1 (06):
  • [40] Antimicrobial Resistance and Prevalence of Extended Spectrum β-Lactamase-Producing Escherichia coli from Dogs and Cats in Northeastern China from 2012 to 2021
    Zhou, Yifan
    Ji, Xue
    Liang, Bing
    Jiang, Bowen
    Li, Yan
    Yuan, Tingyv
    Zhu, Lingwei
    Liu, Jun
    Guo, Xuejun
    Sun, Yang
    ANTIBIOTICS-BASEL, 2022, 11 (11):
12345